Figure 1 | Scientific Reports

Figure 1

From: Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease

Figure 1

The colon mucosa tissue samples were obtained and analyzed using a TMT/LC–MS/MS-based approach for the discovery cohort (intestinal BD, n = 7; CD, n = 7). Candidate protein biomarker validation was performed using tissue IHC staining with the validation cohort 1 (intestinal BD, n = 20; CD, n = 20) and serum ELISA testing with the validation cohort 2 (intestinal BD, n = 20; CD, n = 20).

Back to article page